Author

Jesse J. Balic

The University of MelbourneORCID 0000-0002-9681-6834Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1

Frequent Co-Authors

Andrea GillespieiD· 3 shared Mark A. DawsoniD· 3 shared Ching‐Seng AngiD· 2 shared Dane VassiliadisiD· 2 shared Enid Y.N. LamiD· 2 shared Andrew Das· 1 shared Anelya MuratiD· 1 shared Benjamin J. BlythiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMolecular Biology

Andrea GillespieORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

SF3B3 / SF3B5 form a metazoan specific transcription module of the U2 snRNP that coordinates Pol II elongation in a splicing independent manner

Dane Vassiliadis, Jesse J. Balic, Olivia Braniff, Andrea Gillespie, William Rothnie, Kelsy Prest, Oliver J. Sinclair, Andrew Das, Ching‐Seng Ang, Mark A. Dawson

The paper identifies SF3B3 and SF3B5 as a transcription module within the U2 snRNP that regulates Pol II elongation independently of splicing.

bioRxiv · Jul 15, 2026 · PreprintMolecular Biology

Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemia

Shellaina J.V. Gordon, Florian Perner, Laura MacPherson, Katie A. Fennell, Daniela Vanessa Wenge, Wallace Bourgeois, Tabea Klaus, Thomas Plenge, Anelya Murat, Jelena Petrovic, Jakub Horvath, Joan Q. Cao, John D. Lapek, Sean A. Uryu, Jeffrey R. White, , Mark A. Dawson

The paper shows that inhibiting KAT6/KAT7 enhances Menin inhibitor efficacy and overcomes resistance in MLL-FP leukemia.

Cancer Discovery · Jun 19, 2025Peer-reviewedCancer Biology

Transcription factors use a unique combination of cofactors to potentiate different promoter-dependent steps in transcription

Charles C. Bell, Jesse J. Balic, Laure Talarmain, Andrea Gillespie, Laura Scolamiero, Enid Y.N. Lam, Ching‐Seng Ang, Geoffrey J. Faulkner, Omer Gilan, Mark A. Dawson

The paper identifies cofactors required by different transcription factors and promoters using CRISPR-Cas9 screens and shows that unique cofactor combinations influence transcriptional steps.

Nature Genetics · May 20, 2024Peer-reviewedMolecular Biology